A previous study in gastric cancer patients demonstrated that TIGIT/CD155 signaling downregulates the PI3K-Akt-mTOR pathway in CD8+ T cells, leading to CD8+ T cell exhaustion (27). Here, TIGIT is linked to gastric cancer.